Cytokines pro-inflammatoires, prostaglandines et chondrocyte : Mécanismes d'activation intracellulaire

Revue du Rhumatisme (Edition Francaise)

Volumn 67, Issue 9, 2000, Pages 677-680

  Berenbaum, Francis ^a  

^a CNRS   (France)

Author keywords

Chondrocyte; Cytokines; Intracellular signal; MPA kinases; NF B; Prostagladins; Prostaglandines; Signalisation intracellulaire

Indexed keywords

EID: 0042913201     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1169-8330(00)00025-9     Document Type: Article

References (20)

1. Martel-Pelletier J., Alaaeddine N., Pelletier J.P. Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci. 4:1999;D694-703.
2. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 398:1999;252-256.
3. Firestein G.S., Manning A.M. Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum. 42:1999;609-621.
4. Baldwin A.S. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 14:1996;649-681.
5. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J M. 336:1997;1066-1071.
6. Mengshol J.A., Vincenti M.P., Coon C.I., Barchowsky A., Brinckerhoff C.E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 43:2000;801-811.
7. Kuhn K., Hashimoto S., Lotz M. IL-1 beta protects human chondrocytes from CD95-induced apoptosis. J Immunol. 164:2000;2233-2239.
8. Martel-Pelletier J., Mineau F., Jovanovic D., Di Battista J.A., Pelletier J.P. Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated proten kinase (MAPKAPK). Arthritis Rheum. 42:1999;2399-2409.
9. Shalom-Barak T., Quach J., Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem. 273:1998;27467-27473.
10. Murakami S., Lefebvre V., Crombrugghe B. de. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. J Biol Chem. 275:2000;3687-3692.
11. Garrington T.P., Johnson G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol. 11:1999;211-218.
12. 2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. J Clin Invest. 98:1996;2425-2430.
13. Miller C., Zhang M., He Y., Zhao J., Pelletier J.P., Martel-Pelletier J., et al. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. J Cell Biochem. 15 ; 69:1998;392-413.
14. Berenbaum F., Thomas B., Crofford L.J., Biou H., Humbert L., Salvat C., et al. Regulation of the cyclooxygenase-2 promoter in articular chondrocyte [abstract]. Arthritis Rheum. 42:1999.
15. Mengshol J.A., Vincenti M.P., Coon C.I., Barchowsky A., Brinckerhoff C.E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 43:2000;801-811.
16. Badger A.M., Cook M.N., Lark M.W., Newman-Tarr T.M., Swift B.A., Nelson A.H., et al. SB203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes. J Immunol. 161:1998;467-473.
17. Coleman R.A., Smith W.L., Narumiya S. International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev. 46:1994;205-229.
18. Del Toro F. Jr, Sylvia V.L., Schubkegel S.R., Campos R., Dean D.D., Boyan B.D., et al. Characterization of prostaglandin E(2) receptors and their role in 24,25-(OH)(2)D(3)-mediated effects on resting zone chondrocytes. J Cell Physiol. 182:2000;196-208.
19. Kersten S., Desvergne B., Wahli W. Roles of PPARs in health and disease. Nature. 405:2000;421-424.
20. Bordji K., Grillasca J.P., Gouze J.N., Magdalou J., Schohn H., Keller J.M., et al. Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and retinoid Z receptor in cartilage. PPARgamma activation modulates the effects of interleukin-1beta on rat chondrocytes. J Biol Chem. 275:2000;12243-12250.